Seeing Is Believing
Currently out of the existing stock ratings of Marie Thibault, 97 are a BUY (92.38%), 8 are a HOLD (7.62%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 52.05% that have a potential upside of 35.46% achieved within 93 days.
Marie Thibault’s has documented 212 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PODD, Insulet at 09-Aug-2024.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$124
$12.27 (10.98%)
$120
4 days ago
4/7 (57.14%)
$10.44 (9.19%)
397
Buy
$143
$31.27 (27.99%)
$140
2 months 6 days ago
13/23 (56.52%)
$38.23 (36.49%)
310
Buy
$119
$7.27 (6.51%)
$126
4 months 13 days ago
7/15 (46.67%)
$14.73 (14.13%)
301
Buy
$127
$15.27 (13.67%)
$124
8 months 10 days ago
12/19 (63.16%)
$15.7 (14.11%)
193
Buy
$125
$13.27 (11.88%)
$125
8 months 11 days ago
6/7 (85.71%)
$15.36 (14.01%)
259
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?